---
schema_version: "secwatch.filing_event.v1"
accession: "0001224608-23-000067"
form_type: "8-K"
ticker: "CNO"
cik: "0001224608"
company_name: "CNO Financial Group, Inc."
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T04:39:32.090608+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CNO extends CEO Bhojwani's contract to 2028 and renews poison pill through 2026

## Summary
- CEO Gary C. Bhojwani employment term extended to April 1, 2028 with auto-renewal provisions.
- Fifth Amended Section 382 Rights Agreement extends poison pill to November 13, 2026 to protect NOLs.
- Rights Agreement purchase price set at $110.00 per one-thousandth of Series F Preferred Stock.
- Rights Agreement requires shareholder approval at 2024 annual meeting; otherwise expires Nov 10, 2024.

## SEC filing metadata
- accession: 0001224608-23-000067
- form_type: 8-K
- ticker: CNO
- cik: 0001224608
- company_name: CNO Financial Group, Inc.
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.03, 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1224608/000122460823000067/0001224608-23-000067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1224608/000122460823000067/cno-20231110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001224608-23-000067
- JSON: https://secwatch.observer/filing/0001224608-23-000067.json
- Plain text: https://secwatch.observer/filing/0001224608-23-000067.txt

## Key facts
- Governance Changes
  CNO Financial Group, Inc.: Filing of Certificate of Designations for Series F Junior Participating Preferred Stock and Certificate of Elimination for Series E Junior Participating Preferred Stock in connection with amended rights agreement (effective 2023-11-13).
  - Change: charter amendment
  - Effective: 2023-11-13
  source text: the Company will file with the office of the Secretary of State of the State of Delaware (i) on November 13, 2023 a Certificate of Designations (the “ Certificate of Designations ”) for the Series F Junior Participating Preferred Stock, par value $0.01 per share, of the Company relating to the Amended Rights Agreement, and (ii) on November 14, 2023 a Certificate of Elimination (the “ Certificate of Elimination ”) for the Series E Junior Participating Preferred Stock, par value $0.01 per share, of the Company relating to the Fourth Amended Rights Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1224608/000122460823000067/0001224608-23-000067-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.